Alfacort (Hydrocortisone)

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Alfacort (Hydrocortisone)

What is Alfacort (Hydrocortisone)?

Alfacort is a topical corticosteroid medication containing the active ingredient hydrocortisone. It is classified as a low-potency corticosteroid and is primarily used to manage various inflammatory and allergic skin conditions. By mimicking the actions of naturally occurring hormones produced by the adrenal glands, it helps to modulate the body's local immune response.

Therapeutic Purpose

The primary function of Alfacort is to provide symptomatic relief from localized skin irritation. When applied to the skin, it works to reduce the physical manifestations of inflammation. This includes the management of:

  • Redness (Erythema): Diminishing the visible vascular congestion in the affected area.
  • Swelling (Edema): Reducing the localized accumulation of fluid in the skin tissues.
  • Itching (Pruritus): Calming the nerve endings and chemical signals that trigger the urge to scratch.

Mechanism of Action

Hydrocortisone, the active agent in Alfacort, functions by penetrating the skin cells to suppress the release of various inflammatory substances. It inhibits the activity of chemicals such as prostaglandins and leukotrienes, which are responsible for widening blood vessels and attracting immune cells to the site of an injury or irritation. By stabilizing these cellular processes, the medication helps to restore the skin's normal state and prevent further irritation.

Common Applications

Alfacort is utilized for a wide range of non-infective skin disorders where the skin has become overreactive. Common conditions that may be addressed with this medication include:

  • Eczema and Dermatitis: Including atopic, contact, and seborrheic dermatitis.
  • Insect Bites and Stings: To manage the localized allergic reaction and swelling.
  • Rashes: Such as those caused by environmental irritants or mild allergic reactions.

As a low-potency treatment, it is often selected for use on sensitive areas of the skin or for conditions requiring a milder therapeutic approach compared to more concentrated steroid formulations.

Advertisements

What side effects are possible with Alfacort (Hydrocortisone)?

Possible Side Effects and Safety Information

The safety profile of hydrocortisone (Alfacort), a glucocorticosteroid, details potential adverse reactions based on their frequency, the physiological system affected, and the duration of exposure, as documented by regulatory agencies.

Adverse Reaction Scope

Feature Description
Key Adverse Reaction Categories Systemic effects (e.g., metabolic, endocrine changes) and localized effects (e.g., skin changes) [Systemic Hydrocortisone Label].
Frequency Classification Common reactions often include fluid retention, elevated blood pressure, mood changes (e.g., insomnia, euphoria), and digestive upset. Rare/Uncommon reactions include peptic ulceration, osteoporosis, and bone necrosis [EMA SmPC].
System-Organ Classes Involved Adverse effects are classified across multiple systems, including Endocrine, Psychiatric, Gastrointestinal, Musculoskeletal, and Ophthalmic disorders [FDA DailyMed].

Serious Adverse Reactions and Safety Patterns

Serious Adverse Reactions explicitly listed in regulatory safety information include suppression of the Hypothalamic-Pituitary-Adrenal (HPA) axis, which can lead to adrenal insufficiency if the medicine is abruptly stopped after prolonged use. Other serious risks involve severe psychiatric features and critical ocular effects like glaucoma and cataracts, typically with long-term systemic use [FDA DailyMed].

Dose- or Exposure-Related Patterns indicate that serious effects such as osteoporosis, Cushingoid features, and cataracts are generally associated with prolonged or high-dose exposure. Conversely, certain psychiatric disturbances may be more prominent at the initiation of systemic therapy.

Population-Specific Safety Notes include warnings that pediatric patients are at an increased risk for HPA axis suppression and potential linear growth retardation. The medicine is generally contraindicated in individuals with systemic fungal infections or documented hypersensitivity to the drug [NIH MedlinePlus].

Advertisements

Overdose and Emergency Response

The official regulatory profile for hydrocortisone overdose focuses on documenting systemic manifestations that require immediate attention. Documented overdose presentations involve significant fluid and electrolyte disturbances, including sodium and fluid retention, hypertension, potassium loss, and hypokalemic alkalosis.

Serious outcomes associated with excessive exposure include the potential for congestive heart failure in susceptible patients and heart rhythm disturbances, which may indicate a more serious clinical outlook. Acute neurologic and psychiatric effects are also documented, encompassing convulsions, signs of increased intracranial pressure, and a spectrum of psychiatric derangements ranging to frank psychotic manifestations.

For prolonged supra-physiologic exposure, the risk of developing a Cushingoid state and manifestations of latent diabetes mellitus is noted in official labeling. Furthermore, long-term excessive doses are officially associated with potential growth retardation in children.

The official regulatory guidance explicitly requires that patients seek immediate medical attention upon known or suspected overdose. Regulators mandate contacting emergency services or a Poison Control Center for immediate assistance. Management is restricted to providing symptomatic and supportive treatment, often requiring comprehensive monitoring of vital signs, fluid status, and cardiac function.

Advertisements

Therapeutic Uses of Alfacort (Hydrocortisone)

What Alfacort (Hydrocortisone) Treats: Main Uses and Benefits

Hydrocortisone is considered relevant across distinct medical domains, primarily to provide supportive relief and assist with maintaining functional stability in situations marked by excessive inflammation or hormonal deficiency. Hydrocortisone is commonly used to help manage conditions including arthritis, severe allergic reactions, lupus, and conditions affecting the lungs, skin, and intestines.


The medication is commonly used to help with groups of symptoms that may appear suddenly or intensify over time, such as the severe itching, redness, and swelling associated with dermatological conditions like eczema and dermatitis, or the profound systemic inflammation seen in acute flare-ups of chronic conditions. It is also applied across domains involving symptoms related to systemic imbalance, specifically adrenocortical insufficiency. This supportive relief may assist patients with coping more steadily with difficult, episodic flares.

“This medication is applied in clinical settings that involve acute or unstable symptom patterns, and may assist with easing the overall burden of symptoms.”

Quick Fact: Relief for Intense Symptom Fluctuation

Hydrocortisone is generally applied when appropriate to help ease the pruritus (severe itching) and erythema (redness) associated with skin rashes, and is relevant for managing acute inflammatory exacerbations in conditions characterized by periods of heightened symptoms.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Alfacort (Hydrocortisone)?

Official regulatory documents define strict eligibility criteria for the use of Hydrocortisone. The medicine is contraindicated for patients with a known hypersensitivity to the drug or any of its components, as well as for those with a systemic fungal infection (for systemic formulations). Absolute restrictions also apply to patients receiving immunosuppressive doses who require live vaccines.

Age and Life Stage Limitations

Population Group Official Eligibility Status
Pediatric Patients Not recommended for certain topical uses in children under two years of age. Chronic therapy requires close monitoring due to the risk of HPA axis suppression.
Pregnancy Category C for topical use; permitted only if the potential benefit justifies the potential risk to the fetus. Systemic replacement therapy is generally compatible.

Conditional Use and Comorbidities

Use of Hydrocortisone requires caution and monitoring in patients with pre-existing conditions such as cirrhosis or hypothyroidism, as these conditions may enhance the drug’s effects. Caution is also advised for individuals with ocular herpes simplex or certain gastrointestinal conditions, including active ulcerative colitis, due to the potential for complications. Official labeling notes that efficacy for some topical products in geriatric patients is not established.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Hydrocortisone is structured around its effects on drug metabolism and pharmacodynamics, as documented in regulatory information.

Pharmacokinetic Interactions

Hydrocortisone clearance is significantly affected by the CYP3A4 enzyme system.

  • Increased Clearance (Reduced Exposure): Co-administration with CYP3A4 enzyme inducers (e.g., Phenobarbital, Phenytoin, Rifampicin, Carbamazepine) is documented to increase the clearance of Hydrocortisone, potentially reducing its therapeutic effect.
  • Decreased Clearance (Increased Exposure): Co-treatment with CYP3A4 enzyme inhibitors (e.g., Ketoconazole, Itraconazole, Ritonavir) inhibits metabolism and is expected to increase blood levels of Hydrocortisone, raising the risk of systemic effects. The food product Grapefruit Juice is also documented as a CYP3A4 inhibitor that increases blood levels.

Pharmacodynamic Interactions and Restrictions

  • Contraindicated Combination: Use of Hydrocortisone at immunosuppressive doses is formally contraindicated with the administration of Live or Live-Attenuated Vaccines.
  • Use with Caution: Caution is advised when Hydrocortisone is used with Acetylsalicylic Acid (Aspirin) in patients with hypoprothrombinaemia. Additionally, the effect of Hydrocortisone is documented as enhanced in patients with Hypothyroidism or Cirrhosis.
Advertisements

Mechanism of Action

How Alfacort (Hydrocortisone) Works: Mechanism of Action

Hydrocortisone's mechanism is initiated by binding to the primary intracellular target, the Glucocorticoid Receptor ( GR), forming a complex that enters the cell nucleus. This complex engages in gene modulation, either suppressing (transrepression) pro-inflammatory genes or activating (transactivation) anti-inflammatory and metabolic genes.

This gene modulation results in anti-inflammatory and immunosuppressive effects. It operates by inhibiting major inflammatory signals like NF-kappa B and AP-1, and by increasing anti-inflammatory proteins like Annexin A1. This action modifies the production of key mediators such as prostaglandins, leukotrienes, and inflammatory cytokines.

As a glucocorticoid, the drug actively influences energy pathways, primarily through promoting gluconeogenesis (glucose creation) in the liver and stimulating the breakdown of protein and fat (catabolism). This mechanism results in a systemic increase in blood glucose concentration and alters the allocation of energy substrates through catabolism.

Hydrocortisone exerts negative feedback on the body's stress response system, the Hypothalamic-Pituitary-Adrenal ( HPA) axis. This central action suppresses the release of CRH and ACTH, resulting in the inhibition of the body's native cortisol production.

Advertisements

Dosage and Administration Information

Official Administration Guidelines for Hydrocortisone

The usage of Hydrocortisone, the active ingredient in Alfacort, is determined by the specific formulation and the official route of administration, which includes Oral (tablets, granules), Parenteral (Intravenous or Intramuscular injection), and Topical (cream, ointment).

Usage Context Standard Dosing and Frequency Pattern
Chronic Replacement (Oral) Typically 15 mg to 25 mg total per day of immediate-release tablets, administered in divided doses (e.g., two to three times daily).
Acute/High-Dose Systemic (IV/IM) Initial doses commonly range from 100 mg to 500 mg, which may be repeated every 2, 4, or 6 hours as required.

For oral administration, immediate-release tablets are generally taken with or after a snack or meal to reduce the chance of stomach discomfort. Modified-release tablets must be swallowed whole with water upon awakening, and are not to be divided or crushed. Injectable powder must be aseptically reconstituted with a sterile diluent before being administered by IV or IM injection.

For long-term systemic use, a fundamental procedural rule is that the dose should not be stopped suddenly, but must be gradually reduced (tapered) over time when discontinuing therapy. Pediatric systemic doses are determined based on the severity of the condition and the patient's body surface area, with replacement doses often calculated per m^2/ day and given in divided doses.

Advertisements

Recent Clinical Evidence

Alfacort is a brand name for the corticosteroid hydrocortisone, which is studied across various clinical settings, including inflammatory skin conditions, septic shock, and severe pneumonia. Recent clinical evidence highlights both established uses and areas where efficacy remains under investigation.

Critical Care and Severe Infections

Hydrocortisone is used as adjunctive therapy in critically ill patients, specifically for septic shock and severe community-acquired pneumonia (CAP). Clinical trials have yielded mixed results, leading to evolving guidance:

  • Septic Shock: Some recent systematic reviews suggest that the addition of fludrocortisone to hydrocortisone may be associated with a lower risk of all-cause mortality compared to hydrocortisone alone. Hydrocortisone has also been linked to a reduced requirement for kidney replacement therapy (KRT) in patients with septic shock.
  • Severe CAP: Studies investigating hydrocortisone use in severe CAP have shown varied outcomes. One large randomized trial reported a significantly lower risk of death at 28 days compared to placebo. However, other large-scale adaptive trials suggest that hydrocortisone is unlikely to provide a large reduction in mortality in all severe CAP patients.

Other Investigational Uses

Research is ongoing into specialized delivery methods and patient groups:

  • Adrenocortical Insufficiency: Continuous subcutaneous hydrocortisone infusion (CSHI) is being studied as an alternative to oral replacement therapy. Initial systematic reviews show a promising association with improved quality of life and a reduced rate of hospitalization due to adrenal crisis in some adult patients.
  • Bronchopulmonary Dysplasia (BPD) Prevention: Research in preterm infants suggests that early systemic hydrocortisone is a modestly effective therapy for the prevention of BPD, though safety concerns related to intestinal perforation remain an area of cautious investigation.

Key Studies & References

  1. REMAP-CAP: Corticosteroids in Severe Community-Acquired Pneumonia (Adaptive Platform Trial)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Alfacort (Hydrocortisone) (FAQ)

Q: What is Alfacort (Hydrocortisone) used for besides skin rash?

A: According to official regulatory documents, hydrocortisone is indicated for many uses beyond common skin issues. These include treating specific endocrine disorders where replacement therapy may be necessary, and as a treatment for certain rheumatic, allergic, or respiratory diseases.

Q: Does Alfacort help with itching right away?

A: Official product information indicates that for some conditions treated with topical hydrocortisone, symptom improvement, including a reduction in itching, is generally expected to be noticeable within about seven days of starting application. This timeframe indicates that the full therapeutic effect should not be expected instantly.

Q: Is it safe to use Alfacort on the face?

A: Regulatory warnings advise applying topical hydrocortisone with caution to the face. This is because the skin on the face is typically thinner and more sensitive, which may increase the risk of certain adverse effects like skin atrophy (thinning) or the worsening of pre-existing conditions.

Q: How quickly does Alfacort start working on inflammation?

A: Official information regarding the use of topical hydrocortisone indicates that the initial therapeutic effects, such as the reduction of inflammation, are generally expected to be noticeable within about seven days of starting the treatment regimen.

Q: Is Alfacort safe for long-term use?

A: Official documentation indicates that the risk of serious systemic adverse effects is generally associated with prolonged or high-dose exposure, particularly with systemic forms. These serious effects include the suppression of the Hypothalamic-Pituitary-Adrenal (HPA) axis, which regulates the body's natural stress response.

Q: Can Alfacort cause skin thinning if used too often?

A: Regulatory safety information indicates that prolonged use of topical hydrocortisone may be associated with certain localized adverse effects. These include skin atrophy, which is the technical term for the thinning of the skin, and changes to skin fragility.

Q: Can I use Alfacort if I am pregnant or breastfeeding?

A: Official regulatory documents classify the use of topical hydrocortisone during pregnancy in Category C. This means its use is weighed by a healthcare provider, and it is generally only permitted if the potential benefit justifies the potential risk. Furthermore, official information permits its use while breastfeeding, provided the product is not applied directly to the breast area.

Q: Is Alfacort cream safe to use around the eyes?

A: Official regulatory warnings advise applying topical hydrocortisone with precaution to the eyelids and the area around the eyes. This is due to the potential risk of developing ocular effects such as cataracts or glaucoma, which may be associated with the drug's absorption.

Q: What evidence is there supporting the use of hydrocortisone for dermatitis?

A: Official regulatory labels confirm the established use of hydrocortisone for various dermatologic diseases. These conditions, which include atopic dermatitis (eczema) and contact dermatitis, are listed as specific indications based on clinical evidence and established pharmacological use.

Q: What is the difference between over-the-counter and prescription Alfacort?

A: Hydrocortisone products are typically available in both over-the-counter (OTC) and prescription-only formulations. The key distinction often relates to the potency or strength of the medicine, with OTC versions generally being lower in strength compared to prescription-level products.

Q: Will Alfacort make a fungal infection worse?

A: Regulatory warnings advise against using hydrocortisone to treat skin areas affected by certain infections, particularly those caused by fungi like candidiasis. This is because the immunosuppressive nature of the medicine may allow the existing infection to progress or worsen.

Q: Does Alfacort treatment lead to 'steroid rebound' when stopped?

A: Official product labels advise that if the treated condition improves but then reappears or significantly worsens shortly after stopping, patients are advised to consult with a healthcare professional. This phenomenon is often associated with the body adjusting to the cessation of corticosteroid treatment.

Q: How is the Hydrocortisone in Alfacort different from the Hydrocortisone produced by the body?

A: The hydrocortisone in Alfacort is a synthetic compound that is chemically identical to the body's natural hormone, cortisol. It is used to replace or mimic the actions of cortisol in the body, such as reducing inflammation and regulating metabolism.

Q: What does 'topical steroid' mean in simple terms?

A: A 'topical steroid' is the simple term for a medication that is designed to be applied directly to the skin's surface. It contains a glucocorticosteroid, which is a powerful agent intended to reduce local skin issues like inflammation, redness, and itching.

Q: Does research show Alfacort works better than a placebo for mild eczema?

A: Official regulatory labels list specific dermatologic conditions, including atopic dermatitis (eczema), as indications for hydrocortisone use. This designation is based on established clinical evidence that supports its pharmacological action in reducing inflammation and modifying immune responses related to these conditions.

Q: Is it true that diet can affect how well Alfacort works?

A: Regulatory and clinical information indicates that some food items and dietary supplements can potentially interact with hydrocortisone. For example, grapefruit juice is documented as potentially altering the way the body processes the medicine, which could affect its overall concentration.

Q: Can Alfacort cause changes in skin color?

A: Official regulatory information lists changes in skin pigmentation as a potential localized adverse effect of hydrocortisone use. This can include both the lightening (hypopigmentation) and the darkening (hyperpigmentation) of the treated skin areas.

Q: Can I use Alfacort if I have a history of glaucoma?

A: Official product warnings highlight the risk of ocular effects, such as glaucoma, particularly with long-term systemic use or application near the eyes. Due to the established risks, patients with a history of glaucoma often require close monitoring during treatment.

Q: Do I need a prescription for Alfacort cream?

A: Hydrocortisone is available in both over-the-counter (OTC) and prescription-only strengths and formulations. Whether a prescription is required typically depends on the concentration of the active ingredient and the regulatory classification of the specific product.

Q: Can Alfacort be used for treating acne?

A: Regulatory documentation does not list acne as an approved use for hydrocortisone. In fact, official safety information indicates that acne is listed among the potential adverse effects that may be associated with the use of topical corticosteroid products.

Q: What happens if I forget to apply a dose of Alfacort?

A: Official guidance for systemic (oral) hydrocortisone advises a standard procedure for missed doses. Generally, a missed dose should be taken as soon as it is remembered, but if it is nearly time for the next dose, a general principle for systemic hydrocortisone is that a missed dose should not be doubled to avoid excessive exposure.

Q: Is it normal to feel a stinging sensation when first applying Alfacort?

A: Official regulatory safety information lists a burning, stinging, or irritation sensation as a common, mild potential adverse reaction at the application site for topical hydrocortisone. This type of reaction is frequently reported by users.

Q: Can I put makeup over Alfacort cream?

A: Official information advises against using cosmetics or other types of skin care products on the specific areas of the skin being treated with topical hydrocortisone. This is a common precaution related to minimizing potential irritation and ensuring the medicine's effectiveness.

Q: Can Alfacort be used to treat mosquito bites?

A: Topical hydrocortisone is listed in some official sources as an indicated use for the management of skin reactions caused by insect bites. The drug's anti-inflammatory action helps to reduce the swelling, redness, and itching associated with these reactions.

Q: Does the strength of the Alfacort cream matter for certain conditions?

A: The choice of formulation, such as a cream versus an ointment, and the potency of the hydrocortisone product are generally determined by the specific condition being addressed. This selection process is important for matching the treatment to the specific location on the body and the type of skin lesion present.

Q: How long do the effects of one application of Alfacort usually last?

A: The recommended frequency of application for many topical hydrocortisone products is typically once or twice daily. This dosing pattern is based on the pharmacological profile of the medicine, which suggests the effects of a single application are intended to last for a significant period of the day.

Q: Can Alfacort be used on open cuts or wounds?

A: Official warnings advise against applying topical hydrocortisone to skin areas that have open cuts, scrapes, wounds, or severe injury. This precaution is in place to reduce the risk of systemic absorption of the steroid and the potential for certain complications.

Q: Does Alfacort interact with vitamins or herbal supplements?

A: Regulatory and clinical information suggests that hydrocortisone may interact with certain vitamins and herbal supplements. For example, specific interactions have been noted with supplements containing calcium and with the herbal product licorice.

Q: What should I do if my rash seems worse after using Alfacort?

A: Official labeling advises seeking consultation if symptoms worsen, if the condition does not improve within the specified time frame, or if any signs of a severe skin reaction develop. Consultation allows the healthcare provider to ensure the diagnosis remains correct and the treatment is appropriate.

Q: Does Alfacort cream expire and is it still safe to use?

A: All regulated hydrocortisone cream products are required to have an expiration date listed on the label and packaging. This date is established by regulatory guidelines to indicate the time after which the product may become less effective or should no longer be used.

Q: Can I apply other moisturizing lotions at the same time as Alfacort?

A: Clinical information suggests caution when applying other lotions or moisturizers to the same area being treated with hydrocortisone. This practice may increase the amount of the medication absorbed through the skin, which could potentially lead to greater absorption and increase the potential for side effects.

Q: What types of allergic reactions are associated with Alfacort?

A: Regulatory safety information includes hypersensitivity reactions, which is the technical term for allergic reactions, as a possibility. These reactions can manifest as symptoms such as a severe rash, burning, stinging, swelling, or irritation that occurs at the application site.

Q: Does Alfacort (Hydrocortisone) help with nerve pain?

A: Regulatory labels for hydrocortisone do not typically describe it as a primary treatment for general nerve pain (neuropathic pain). Its approved uses are primarily indicated for its action against inflammation, and for treating certain rheumatic and immunologic disorders.

Q: How does Alfacort get absorbed into the body through the skin?

A: Scientific literature confirms that hydrocortisone is absorbed through the skin and enters the bloodstream. The exact amount absorbed can vary widely depending on several factors, including the type of formulation (e.g., cream vs. ointment), the area of the body where it is applied, and the thickness of the application.

Q: What is the purpose of the other ingredients in Alfacort cream?

A: The inactive ingredients in Alfacort cream are included to help formulate the product correctly. Their purpose is to provide the desired consistency for easy application, assist in the stability and preservation of the medication, and sometimes aid the delivery of the active drug.

Advertisements

How should Alfacort (Hydrocortisone) be stored and disposed of?

How to Store and Dispose of Hydrocortisone (Alfacort)

Official regulatory documents specify mandatory conditions for the storage and disposal of Hydrocortisone topical preparations to ensure stability and safety.


Storage and Handling Requirements

The product must be stored at controlled room temperature, defined as 20 C to 25 C (68 F to 77 F). Storage must avoid excessive heat and humidity. It is strictly required that the medication not be frozen and the container be kept tightly closed when not in use. For safety, this and all medicines must be stored out of the reach and sight of children.


Disposal Instructions

Disposal of unused or expired product should be conducted in accordance with local waste disposal regulations for pharmaceuticals. If the product is accidentally swallowed, official instructions mandate immediate contact with a Poison Control Center.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Alfacort (Hydrocortisone) found in:

A-Z Index: